SCHEMBL5605723

SCHEMBL5605723

Cc1ccccc1N(C)CCN(Cc1cc(-c2ccc3c(c2)CCN3)ccc1F)C(=O)c1ccc(F)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 3/20 0.36
▸ OPRD1 P41143 3/20 0.35
▸ ROCK1 Q13464 1/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ OXTR P30559 1/20 0.33
▸ AVPR1A P37288 1/20 0.33
▸ OPRM1 P35372 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ KCNH2 Q12809 2/20 0.32
▸ ABCB11 O95342 1/20 0.32
▸ HTR2C P28335 1/20 0.32
▸ MCHR1 Q99705 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3695118 0.88 OPRD1 (0.39) ACHEOPRD1ROCK1CDK4CCND1
SCHEMBL13611680 0.86 ACHE (0.36) ACHEOPRD1ROCK1CDK4CCND1
SCHEMBL14388564 0.83 ACHE (0.36) ACHEOPRD1ROCK1PARP1KDM4E
SCHEMBL27731815 0.79 ACHE (0.38) ACHEOPRD1ROCK1KDM4EALDH1A1
SCHEMBL27731820 0.74 ACHE (0.38) ACHEOPRD1ROCK1PARP1KDM4E
SCHEMBL3695648 0.69 KDM4E (0.47) ROCK1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL3695341 0.66 NPC1 (0.42) ROCK1CDK4CCND1KDM4EALDH1A1
SCHEMBL3699058 0.64 KDM4E (0.41) ROCK1CDK4CCND1KDM4EALDH1A1
SCHEMBL3692381 0.62 CDK4 (0.43) ROCK1CDK4CCND1KDM4EALDH1A1
SCHEMBL21042092 0.62 ALDH1A1 (0.50) OPRD1KDM4EALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1851199-A1 SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS Aventis Pharmaceuticals, Inc. (US) 2007-11-07 — — EP claimed
WO-2006086705-A1 SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2006-08-17 — — WO claimed
Send feedback